Portal de Periódicos da CAPES

Second‐trimester maternal serum markers and placenta accreta

2012; Wiley; Volume: 32; Issue: 10 Linguagem: Inglês

10.1002/pd.3932

1097-0223

Sophie Dreux, Laurent Salomon, Françoise Müller, François Goffinet, Jean‐François Oury, ABA Study Group, Loı̈c Sentilhes,

Gestational Trophoblastic Disease Studies

Prenatal DiagnosisVolume 32, Issue 10 p. 1010-1012 Research Letter Second-trimester maternal serum markers and placenta accreta Sophie Dreux, Sophie Dreux Biochimie-Hormonologie, Hôpital Robert Debré, AP-HP, Paris, FranceSearch for more papers by this authorLaurent J. Salomon, Laurent J. Salomon Gynécologie-Obstétrique, Hôpital Necker-Enfants Malades, AP-HP, Paris, FranceSearch for more papers by this authorFrançoise Muller, Corresponding Author Françoise Muller Biochimie-Hormonologie, Hôpital Robert Debré, AP-HP, Paris, France Gynécologie-Obstétrique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France Biochimie, Université Paris Ile de France Ouest, Versailles, Saint-Quentin, FranceFrançoise Muller. E-mail: [email protected]Search for more papers by this authorFrançois Goffinet, François Goffinet Gynécologie-Obstétrique, Maternité Port-Royal, Hôpital Cochin, AP-HP, Paris, France French Collaborative Conservative Treatment of Placenta Accreta Study GroupSearch for more papers by this authorJean-François Oury, Jean-François Oury Gynécologie-Obstétrique, Hôpital Robert Debré, AP-HP, Paris, FranceSearch for more papers by this author ABA Study Group, ABA Study Group ABA Study GroupSearch for more papers by this authorLoïc Sentilhes, Loïc Sentilhes French Collaborative Conservative Treatment of Placenta Accreta Study Group Gynécologie-Obstétrique, CHU Angers, Angers, FranceSearch for more papers by this author Sophie Dreux, Sophie Dreux Biochimie-Hormonologie, Hôpital Robert Debré, AP-HP, Paris, FranceSearch for more papers by this authorLaurent J. Salomon, Laurent J. Salomon Gynécologie-Obstétrique, Hôpital Necker-Enfants Malades, AP-HP, Paris, FranceSearch for more papers by this authorFrançoise Muller, Corresponding Author Françoise Muller Biochimie-Hormonologie, Hôpital Robert Debré, AP-HP, Paris, France Gynécologie-Obstétrique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France Biochimie, Université Paris Ile de France Ouest, Versailles, Saint-Quentin, FranceFrançoise Muller. E-mail: [email protected]Search for more papers by this authorFrançois Goffinet, François Goffinet Gynécologie-Obstétrique, Maternité Port-Royal, Hôpital Cochin, AP-HP, Paris, France French Collaborative Conservative Treatment of Placenta Accreta Study GroupSearch for more papers by this authorJean-François Oury, Jean-François Oury Gynécologie-Obstétrique, Hôpital Robert Debré, AP-HP, Paris, FranceSearch for more papers by this author ABA Study Group, ABA Study Group ABA Study GroupSearch for more papers by this authorLoïc Sentilhes, Loïc Sentilhes French Collaborative Conservative Treatment of Placenta Accreta Study Group Gynécologie-Obstétrique, CHU Angers, Angers, FranceSearch for more papers by this author First published: 25 June 2012 https://doi.org/10.1002/pd.3932Citations: 27 Funding sources: None Conflicts of interest: None declared Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1 Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006; 107: 927– 41. 2 Lim P, Greenberg M, Edelson M, et al. Utility of ultrasound ans MRI in prenatal diagnosis of placenta accreta: a pilot study. AJR 2011; 197: 1506– 13. 3 Esakoff TF, Sparks TN, Kaimal AJ, et al. Diagnosis and morbidity of placenta accreta. Ultrasound Obstet Gynecol 2011; 37: 324– 7. 4 Zelop C, Nadel A, Frigoletto FD, et al. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1992; 80: 693– 4. 5 Kupferminc MJ, Tamura RK, Wigton TR, et al. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993; 82: 266– 9. 6 Hung TH, Shau WY, Hsieh CC, et al. Risk factors for placenta accreta. Obstet Gynecol 1999; 93: 545– 50. 7 Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010; 115: 526– 34. 8 Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty years analysis. AJOG 2005; 192: 1458– 61. 9 Warshak CR, Ramos GA, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010; 115: 65– 9. 10 Hourrier S, Salomon LJ, Dreux S, Muller F. Screening for adverse pregnancy outcome at early gestational age. Clin Chim Acta 2010; 411: 1547– 52. Citing Literature Volume32, Issue10October 2012Pages 1010-1012 ReferencesRelatedInformation